RTW Investments, LP 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:22 am Sale |
2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
RTW Investments, LP | 0 0.000% |
-6,029,700 (Position Closed) |
Filing |
| 2022-02-14 08:58 am Purchase |
2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
RTW Investments, LP | 6,029,700 9.200% |
161,374 (+2.75%) |
Filing |
| 2021-12-08 2:06 pm Purchase |
2021-11-29 | 13G | CytomX Therapeutics, Inc. CTMX |
RTW Investments, LP | 5,868,326 8.990% |
5,868,326 (New Position) |
Filing |